SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012956
Filing Date
2018-05-10
Accepted
2018-05-10 16:16:18
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bold-10q_20180331.htm 10-Q 1610776
2 EX-31.1 bold-ex311_46.htm EX-31.1 7882
3 EX-31.2 bold-ex312_47.htm EX-31.2 7873
4 EX-32.1 bold-ex321_44.htm EX-32.1 6483
5 EX-32.2 bold-ex322_45.htm EX-32.2 6296
  Complete submission text file 0001564590-18-012956.txt   5828468

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bold-20180331.xml EX-101.INS 1319635
7 XBRL TAXONOMY EXTENSION SCHEMA bold-20180331.xsd EX-101.SCH 37855
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bold-20180331_cal.xml EX-101.CAL 36209
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bold-20180331_def.xml EX-101.DEF 237401
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20180331_lab.xml EX-101.LAB 293579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20180331_pre.xml EX-101.PRE 281048
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37833 | Film No.: 18822722
SIC: 2836 Biological Products, (No Diagnostic Substances)